Search results
AI plus gene editing promises to shift biotech into high gear
The Conversation via Yahoo News Singapore· 2 months agoAI has learned the ins and outs of proteins. Gene editing gives scientists control of life’s...
CRISPR treatment has been greenlit in UK in global first. Here’s who it could help
CNN via Yahoo Style Singapore· 8 months agoThe United Kingdom has become the first country to give regulatory approval to a medical treatment...
FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease
CNN via Yahoo Style Singapore· 8 months agoThe US Food and Drug Administration on Friday approved two gene-based treatments for sickle cell...
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2...
Business Insider via Yahoo News Singapore· 8 months agoThe FDA approved the first gene therapy for sickle cell anemia.Meletios Verras/ iStock The FDA...
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 3 months agoEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine,...
FDA Approves First CRISPR Treatment in U.S.
Time via Yahoo Style Singapore· 8 months agoSickled blood cells forming clumps in a vessel Credit - Getty Images It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier...
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo Singapore Finance· 3 months agoEditas Medicine, Inc. EDIT incurred a loss of 76 cents per share in the first quarter of 2024, wider...
CRISPR Therapeutics and Dollar General have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Singapore Finance· 8 months agoFor Immediate Release Chicago, IL – December 11, 2023 – Zacks Equity Research shares CRISPR...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via Yahoo Singapore Finance· 3 months agoRegeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop and commercialize gene editing therapies for multiple diseases, the companies said on Thursday. Mammoth's ...
UPDATE 2-US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder
Reuters via Yahoo Singapore Finance· 6 months agoThe U.S. health regulator has approved Vertex Pharmaceuticals and CRISPR Therapeutics' gene therapy to treat a rare blood disorder requiring regular blood transfusions, in patients 12 years ...